KindVR   Report issue

For profit
Founded: Alameda CA United States (2014)
Status: No NME R&D (2014)

Organization Overview

First Clinical Trial
2017
NCT03239743
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

KindVR

Active Ingredients

Drugs in Other Trials (1)

midazolam (versed) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1